Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

1.87
Delayed Data
As of 4:00pm ET
 -0.05 / -2.60%
Today’s Change
1.71
Today|||52-Week Range
5.30
+1.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues11.2M3.0M34.4M11.5M
 
 
 
 
 
Cost of Goods Sold4.0M1.3M4.5M1.9M
 
 
 
 
 
Depreciation And Amortization3.1M3.6M3.7M3.5M
 
 
 
 
 
 
Operating ExpensesGross Income4.1M-2.0M26.3M6.1M
 
 
 
 
 
General Expenses29.1M34.6M37.5M40.7M
 
 
 
 
 
Other Operating Expenses5.0M0.000.000.00
 
 
Research And Development22.5M28.0M28.7M33.3M
 
 
 
 
 
Total Operating Expenses41.2M39.5M45.6M46.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-29.9M-36.5M-11.2M-34.6M
 
 
 
 
 
Extraordinary Charge-43.0K-10.0K-1.0M-1.0M
 
 
 
 
 
Interest Expense On Debt0.000.000.00674.0K
 
 
Other Expenses0.000.000.008.5M
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-29.0M-36.5M-11.6M-27.8M
 
 
 
 
 
Net Income-29.0M-36.5M-11.6M-27.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS81.0M84.6M90.8M92.4M
 
 
 
 
 
Shares To Calculate EPS Diluted81.0M84.6M90.8M92.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.36-$0.43-$0.13-$0.30
 
 
 
 
 
EPS Diluted-$0.36-$0.43-$0.13-$0.30
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account